NCT06004362

Brief Summary

The Post-COVID syndrome is a COVID-19 sequelae disease with high individual burden. We conduct a prospective, two-arm, randomized-controlled intervention study with embedded qualitative and physiological sub-studies in a mixed-methods design.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 22, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

September 4, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 23, 2024

Status Verified

January 1, 2024

Enrollment Period

1.8 years

First QC Date

August 17, 2023

Last Update Submit

January 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Short Form 36 (SF-36), Physical Functioning Scale

    The scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.

    Baseline, 10 weeks

Secondary Outcomes (19)

  • Short Form 36 (SF-36)

    Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks

  • DePaul Post-Exertional Malaise Questionnaire (DSQ-PEM)

    Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks

  • Post-COVID-Syndrom (PCS) Score

    Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks

  • Chalder Fatigue Scale (CFS)

    Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks

  • Quality of life (EQ-5D-5L)

    Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks

  • +14 more secondary outcomes

Other Outcomes (3)

  • Qualitative data

    Week 10

  • Sub-study: Focus group interviews with physicians

    Week 10

  • Sub-study: biosignal characteristics

    Baseline, week 10

Study Arms (2)

Complementary and Integrative Medicine online intervention, routine care and book

EXPERIMENTAL
Behavioral: Complementary and Integrative Medicine online intervention, routine care and book

Routine care and book

ACTIVE COMPARATOR
Behavioral: Routine care and book

Interventions

The online program takes place in a multiprofessionally guided online group setting once a week for up to 180 minutes (including several breaks) over a period of 10 weeks: * Basic principles of a plant-based whole-food nutrition * Procedures of hydrotherapy according to Kneipp * Self-help strategies (e.g. teas, wraps, compresses etc.) * Methods of mind-body medicine (mindfulness, meditation, breathing, yoga etc.) * Methods of extended Complementary and Integrative Medicine (e.g. acupressure) It is recommended to practice a part of the taught exercises at home for about 30 minutes daily. In addition, the patients receive a book for the treatment of post-covid syndrome complaints. Group 1 additionally uses the already existing routine care (e.g. general practitioner).

Complementary and Integrative Medicine online intervention, routine care and book

Participants in the second study arm receive routine care, e.g. from their general practitioner. In addition, the patients receive the same book as group 1 for the treatment of post-covid syndrome complaints. The participants of the second study arm will be offered to participate in the Complementary and Integrative Medicine online intervention after 4 months within the study.

Routine care and book

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute SARS-CoV2 infection at least 12 weeks ago (documented by PCR test results or SARS-CoV-2 antibodies)
  • History of chronic fatigue (after SARS-CoV-2 infection)
  • Numerical Rating Scale (NRS, 0-10 points, 0 = not able to exercise at all; 10 = full exercise capacity) physical exercise capacity of max. 6 points ("What is your physical exercise capacity on average over the last 7 days?")
  • Short Form-36 Physical Function Subscale (SF-36 PFS) of maximum 65 points
  • Patient are technically equipped enough to participate in the online intervention and willing to follow the study procedure to perform the online intervention at home

You may not qualify if:

  • Fatigue already present before SARS-CoV-2 infection
  • Presence of severe post-exertional malaise (PEM) (according to DSQ-PEM tool question 7 OR 8 with yes AND \>14h condition worsening)
  • Other underlying conditions leading to symptoms of chronic fatigue, such as unstable mental illness, oncological disease(s), MS, fibromyalgia, and substance abuse
  • Other serious underlying medical conditions, such as severe pulmonary, cardiac, psychiatric, or infectious diseases that could interfere with study participation or affect results • Ongoing opioid therapy or opioid therapy in the week prior to study entry
  • Regular use of cannabinoids or other illicit drugs in the month prior to or during the study
  • Restarting or discontinuing psychotherapy during study participation in the 6 weeks prior to study entry
  • Pregnancy or breastfeeding
  • Participation in another clinical intervention study during study participation 1
  • Regular use of Complementary and Integrative Medicine self-help measures (e.g. meditation, Kneipp hydrotherapiy, etc.) within the study period
  • Current pension procedure or planned claiming of a pension procedure due to disability
  • Planned rehabilitation measures during study participation due to post-COVID syndrome
  • Family physicians and general practitioners
  • Regular outpatient care of patients with post-covid syndrome
  • Willingness in principle to participate in a 2-hour interview on-site or online
  • No previous care of post-covid patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus

Berlin, 14109, Germany

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 17, 2023

First Posted

August 22, 2023

Study Start

September 4, 2023

Primary Completion

July 1, 2025

Study Completion

December 1, 2025

Last Updated

January 23, 2024

Record last verified: 2024-01

Locations